Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma

PURPOSE: Vaccination with hybridoma-derived autologous tumor immunoglobulin (Ig) idiotype (Id) conjugated to keyhole limpet hemocyanin (KLH) and administered with granulocyte-monocyte colony-stimulating factor (GM-CSF) induces follicular lymphoma (FL) –specific immune responses. To determine the cli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schuster, Stephen J., Neelapu, Sattva S., Gause, Barry L., Janik, John E., Muggia, Franco M., Gockerman, Jon P., Winter, Jane N., Flowers, Christopher R., Nikcevich, Daniel A., Sotomayor, Eduardo M., McGaughey, Dean S., Jaffe, Elaine S., Chong, Elise A., Reynolds, Craig W., Berry, Donald A., Santos, Carlos F., Popa, Mihaela A., McCord, Amy M., Kwak, Larry W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2011
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3139394/
https://ncbi.nlm.nih.gov/pubmed/21632504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.33.3005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados